New York woman who duped investors, funneled money to 2017 Trump fundraiser pleads guilty
Sherry Xue Li, 48, of Oyster Bay, pleaded guilty Wednesday in federal court on Long Island to money laundering conspiracy and conspiracy to defraud the U.S. by obstructing the Federal Election Commission's administration of campaign finance laws. She faces up to 20 years in prison and is set to be sentenced on Dec. 5.
Her lawyer, Kevin Keating, declined to comment on the plea and the charges Wednesday. She has been detained since her arrest in 2022.
Li's co-defendant, Lianbo Wang, pleaded guilty to similar charges in March 2024 and was sentenced to five years in prison.
Prosecutors say the scheme went on for nearly a decade. Li and Wang coaxed investors, many of whom were from China, into contributing $500,000 each to a fictitious development project, with a false promise to guarantee them lawful permanent resident status in the U.S., authorities said. They used millions of dollars from those investments for personal expenses, including clothing, jewelry, housing, vacation travel and upscale dining, officials said.
Li and Wang also sold investors access to U.S. politicians at fundraisers and used the proceeds to illegally contribute millions of dollars to U.S. political campaigns and committees. The campaigns and committees were unaware of the scheme, and no allegations of criminal wrongdoing were lodged against them, prosecutors said.
On June 28, 2017, Trump attended a fundraiser for his 2020 reelection bid at his hotel in Washington. Prosecutors said Li and Wang charged each of the 12 foreign nationals $93,000 for admission to the event, then used the funds to make illegal contributions in their names totaling $600,000 to the fundraising committee hosting the event.
Li took a photograph with Trump and his wife, Melania, at the event and would later use it to solicit donations to the fake development project, prosecutors said.
Other investors or prospects also received brochures featuring Li or Wang with Trump and other politicians, including Democratic then-New York Gov. Andrew Cuomo, prosecutors said.
Li and Wang, who are naturalized U.S. citizens, also contributed millions of dollars to other federal, state and local campaigns, which were not identified by authorities.
'Li defrauded more than 150 victims in the United States and abroad through years of lies and deception and sought to profit by selling access to the democratic process,' Joseph Nocella Jr., U.S. attorney for the Eastern District of New York, said in a statement. 'In doing so, she attempted to corrupt a fundamental institution in this country — fair and transparent elections free from unlawful foreign influence.'
As part of her plea agreement, Li agreed to forfeit $31.5 million and three properties.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Cardinal Health expands urology focus with $1.9bn Solaris Health deal
US drug distributor Cardinal Health has signed a $1.9bn agreement to acquire a majority stake in Solaris Health from Lee Equity Partners. The deal aims to expand the Specialty Alliance, the distributor's multi-speciality management services organisation (MSO) platform, in which Cardinal will gain a stake of around 75%. The acquisition will also create the Urology Alliance, comprising a collaborative network of urology providers within Cardinal's Specialty Alliance MSO, as well as resonate with plans to expand the delivery of urological patient care. Cardinal's Solaris buyout complements its recent acquisitions of Urology America, Potomac Urology, and Academic Urology & Urogynaecology, signalling its urologic strategy. The transaction is expected to be completed by the end of this year, pending customary closing conditions. Cardinal Health CEO Jason Hollar stated that growing the Speciality Alliance is a 'top priority' for the company, with the latest urology purchase leaving it 'well-positioned to meet the comprehensive needs of community urologists through the robust combined capabilities of the Specialty Alliance, Specialty Networks and Cardinal Health'. Research indicates there is a shortage of urologists in the US, with 62% of US counties lacking a practising urologist and just one new urologist entering the field for every ten retiring. The figures lead to challenges in the broader field, including delayed diagnoses, increased rates of advanced-stage conditions, and significant health disparities, with these particularly pronounced in rural communities. GlobalData's senior medical analyst Selena Yu foresees Cardinal's acquisition as reflecting a shift from drug distribution with a 'lower profit margin, towards higher margin speciality care in urology'. Yu said: 'MSOs help streamline backend work like billing and staffing to allow for physicians to focus on care. 'Additionally, with a large network of specialists, patients can receive care in the same region by different care specialists, which will reduce wait times and improve care continuity. Additionally, the Cardinal Health Alliance has other specialities like oncology specialists, which makes referrals more streamlined.' Cardinal's acquisition coincided with the release of its Q4 2025 financials. The company's profits per share came in at $2.08, beating the forecasted $2.03, yet profits for the quarter came in at $60.2bn, below the $60.92bn forecast, prompting a pre-market stock drop of more than 11% on 12 August. Cardinal's share price has since recovered to a drop of around 6% to $147.05 per share, down from $157.66 per share at market close on 11 August. "Cardinal Health expands urology focus with $1.9bn Solaris Health deal" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Effettua l'accesso per consultare il tuo portafoglio
Yahoo
15 minutes ago
- Yahoo
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement that the company bribed and illegally induced medical providers to prescribe its most profitable drugs, including the GLP-1 medications Mounjaro and Zepbound, used for weight loss and diabetes treatment. "Big Pharma compromised medical decision-making by engaging in an illegal kickback scheme," Attorney General Paxton said. The lawsuit builds upon Attorney General's previous legal action to hold drug manufacturers accountable for fraud and abuse, the statement added. Last year, Paxton had sued insulin manufacturers, including Lilly and pharmacy benefit managers (PBMs), alleging that manufacturers artificially raised the prices of insulin and then paid a significant, undisclosed portion back to the PBMs for preferential treatment in return. Eli Lilly did not immediately respond to a Reuters request for comment. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
15 minutes ago
- Yahoo
US Equity Indexes Jump After July Inflation Boosts Fed Rate-Cut Expectations
US equity indexes jumped in midday trading Tuesday, with the Nasdaq Composite and S&P 500 hitting al